Movement Alert｜Hims & Hers Health Inc. Falls 5.12% in Regular Trading, Visa Monitoring Program and Barclays Target Cut Continue to Weigh

Market Focus08-26 23:37

On August 26, Hims & Hers Health Inc. declined 5.12% in regular trading, trading at $30.09 per share, with turnover of $121 million. The stock faced continued selling pressure from multiple headwinds including Visa's monitoring program and a target price reduction from Barclays.

The company was enrolled in Visa's Acquirer Monitoring Program after a surge in credit card disputes in its weight-loss subscription business in July. Each dispute carries an $8 surcharge, resulting in a projected bill of nearly $75,000 in September. The company must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program. Separately, Barclays cut its price target from $39 to $35 while maintaining an Overweight rating.

Hims & Hers Health, Inc. operates a telehealth consultation platform connecting consumers to healthcare professionals, enabling access to medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1187024319?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-26 23:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1187024319","market":"us","top_or_hot":-1,"title":"Movement Alert｜Hims & Hers Health Inc. Falls 5.12% in Regular Trading, Visa Monitoring Program and Barclays Target Cut Continue to Weigh","media":"Market Focus","content":"<p><p>On August 26, Hims & Hers Health Inc. declined 5.12% in regular trading, trading at $30.09 per share, with turnover of $121 million. The stock faced continued selling pressure from multiple headwinds including Visa's monitoring program and a target price reduction from Barclays.</p><p>The company was enrolled in Visa's Acquirer Monitoring Program after a surge in credit card disputes in its weight-loss subscription business in July. Each dispute carries an $8 surcharge, resulting in a projected bill of nearly $75,000 in September. The company must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program. Separately, Barclays cut its price target from $39 to $35 while maintaining an Overweight rating.</p><p>Hims & Hers Health, Inc. operates a telehealth consultation platform connecting consumers to healthcare professionals, enabling access to medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Hims & Hers Health Inc. Falls 5.12% in Regular Trading, Visa Monitoring Program and Barclays Target Cut Continue to Weigh</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Hims & Hers Health Inc. Falls 5.12% in Regular Trading, Visa Monitoring Program and Barclays Target Cut Continue to Weigh\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-26 23:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 26, Hims & Hers Health Inc. declined 5.12% in regular trading, trading at $30.09 per share, with turnover of $121 million. The stock faced continued selling pressure from multiple headwinds including Visa's monitoring program and a target price reduction from Barclays.</p><p>The company was enrolled in Visa's Acquirer Monitoring Program after a surge in credit card disputes in its weight-loss subscription business in July. Each dispute carries an $8 surcharge, resulting in a projected bill of nearly $75,000 in September. The company must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program. Separately, Barclays cut its price target from $39 to $35 while maintaining an Overweight rating.</p><p>Hims & Hers Health, Inc. operates a telehealth consultation platform connecting consumers to healthcare professionals, enabling access to medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"","article_id":"1187024319","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187024319","pubTimestamp":1787758656,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 26, Hims & Hers Health Inc. declined 5.12% in regular trading, trading at $30.09 per share, with turnover of $121 million. The stock faced continued selling pressure from multiple headwinds...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"走势警报|Hims & Hers Health Inc. 常规交易下跌 5.12%，签证监控计划和巴克莱目标下调继续承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":1},"content_text":"On August 26, Hims & Hers Health Inc. declined 5.12% in regular trading, trading at $30.09 per share, with turnover of $121 million. The stock faced continued selling pressure from multiple headwinds including Visa's monitoring program and a target price reduction from Barclays.The company was enrolled in Visa's Acquirer Monitoring Program after a surge in credit card disputes in its weight-loss subscription business in July. Each dispute carries an $8 surcharge, resulting in a projected bill of nearly $75,000 in September. The company must bring its dispute rate below 1.5% of transactions for three consecutive months to exit the program. Separately, Barclays cut its price target from $39 to $35 while maintaining an Overweight rating.Hims & Hers Health, Inc. operates a telehealth consultation platform connecting consumers to healthcare professionals, enabling access to medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1187024319","isCrawlerRequest":true}